Corix Bioscience, Inc. (CXBS) SEC Filing 10-Q Quarterly report for the period ending Friday, June 30, 2017

Corix Bioscience, Inc.

CIK: 1433821 Ticker: CXBS
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2017
Jul. 10, 2017
Document And Entity Information  
Entity Registrant NameCORIX BIOSCIENCE, INC. 
Entity Central Index Key0001433821 
Document Type10-Q 
Document Period End DateJun. 30, 2017 
Amendment Flagfalse 
Current Fiscal Year End Date--12-31 
Is Entity a Well-known Seasoned Issuer?No 
Is Entity a Voluntary Filer?No 
Is Entity's Reporting Status Current?Yes 
Entity Filer CategorySmaller Reporting Company 
Entity Common Stock, Shares Outstanding 19,789,929
Document Fiscal Period FocusQ2 
Document Fiscal Year Focus2017 

View differences made from one quarter to another to evaluate Corix Bioscience, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Corix Bioscience, Inc..


Assess how Corix Bioscience, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Corix Bioscience, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Commitments And Contingencies
Commitments And Contingencies (details Narrative)
Common Stock
Common Stock (details Narrative)
Convertible Debenture
Convertible Debenture (details Narratives)
Discontinued Operations
Discontinued Operations (details Narrative)
Discontinued Operations (tables)
Discontinued Operations - Balance Sheet (details)
Discontinued Operations - Cash Flows (details)
Discontinued Operations - Future Minimum Rental Revenues Under Leases (details)
Discontinued Operations - Investment In Real Estate - (details)
Discontinued Operations - Notes Payable (details)
Discontinued Operations - Prepaid Rent Received (details)
Discontinued Operations - Schedule Of Principal Payments (details)
Discontinued Operations - Single Family Residence Acquisitions (details)
Discontinued Operations - Statements Of Operations (details)
Going Concern
Going Concern (details Narrative)
Nature Of Operations
Nature Of Operations (details Narrative)
Related Party Transactions
Related Party Transactions (details Narrative)
Reverse Acquisition
Share Purchase Warrants
Share Purchase Warrants (tables)
Share Purchase Warrants - Warrants Issued (details)
Share Purchase Warrants - Warrants Outstanding (details)
Stock Options
Stock Options (details Narrative)
Stock Options (tables)
Stock Options - Assumption (details)
Stock Options - Option Activity (details)
Stock Options - Options Outstanding And Exercisable (details)
Subsequent Events
Subsequent Events (details Narrative)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (details Narrative)
Summary Of Significant Accounting Policies (policies)

Material Contracts, Statements, Certifications & more

Corix Bioscience, Inc. provided additional information to their SEC Filing as exhibits

Ticker: CXBS
CIK: 1433821
Form Type: 10-Q Quarterly Report
Accession Number: 0001659173-17-000400
Submitted to the SEC: Mon Aug 21 2017 12:17:53 PM EST
Accepted by the SEC: Mon Aug 21 2017
Period: Friday, June 30, 2017
Industry: Operators Of Nonresidential Buildings

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: